Beyranvand Mohammad Reza, Manhoobi Hootan, Shahraz Saeid, Kolahi Ali-Asghar
Department of Cardiology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Tehran Heart Cent. 2023 Apr;18(2):82-86. doi: 10.18502/jthc.v18i2.13316.
Cardiovascular diseases, specifically acute myocardial infarction (AMI), are the leading cause of death worldwide. In this review, we explain the characteristics of AMI in Iran.
We searched PubMed, Google, and Google Scholar for articles containing myocardial infarction, STEMI, and MI Iran in English and Persian words.
The age-standardized incidence rate of MI was 73.3 per 100 000. The mean±SD age of patients was 61.20±13.40 years. In-hospital mortality of patients with AMI in the IMIR was 12.1%. Concerning AMI complications reported in the IMIR, 5.8% of patients experienced ventricular tachycardia, and 2.5% experienced ventricular fibrillation. The 1-year mortality rate in the IPACE2 study was 4.3%.
Only a few national studies are available in Iran regarding patients with AMI. A federal surveillance program continuously monitoring and tracking coronary events is essential to improve the general population's health.
心血管疾病，尤其是急性心肌梗死（AMI），是全球主要的死亡原因。在本综述中，我们阐述了伊朗急性心肌梗死的特征。
我们在PubMed、谷歌和谷歌学术上搜索了包含英文和波斯文的心肌梗死、ST段抬高型心肌梗死和伊朗心肌梗死的文章。
心肌梗死的年龄标准化发病率为每10万人73.3例。患者的平均年龄±标准差为61.20±13.40岁。伊朗心肌梗死注册研究（IMIR）中急性心肌梗死患者的院内死亡率为12.1%。关于IMIR中报告的急性心肌梗死并发症，5.8%的患者发生室性心动过速，2.5%的患者发生心室颤动。IPACE2研究中的1年死亡率为4.3%。
伊朗关于急性心肌梗死患者的全国性研究较少。一个持续监测和跟踪冠心病事件的联邦监测项目对于改善普通人群的健康至关重要。
